204 related articles for article (PubMed ID: 28939160)
1. Hepatocellular carcinoma with neuroendocrine differentiation: a case report.
Lu JG; Farukhi MA; Mayeda D; French SW
Exp Mol Pathol; 2017 Oct; 103(2):200-203. PubMed ID: 28939160
[TBL] [Abstract][Full Text] [Related]
2. Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): a case report and review of the literature.
Garcia MT; Bejarano PA; Yssa M; Buitrago E; Livingstone A
Virchows Arch; 2006 Sep; 449(3):376-81. PubMed ID: 16896889
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma with an unusual neuroendocrine component.
Yamaguchi R; Nakashima O; Ogata T; Hanada K; Kumabe T; Kojiro M
Pathol Int; 2004 Nov; 54(11):861-5. PubMed ID: 15533230
[TBL] [Abstract][Full Text] [Related]
4. Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature.
Choi GH; Ann SY; Lee SI; Kim SB; Song IH
World J Gastroenterol; 2016 Nov; 22(41):9229-9234. PubMed ID: 27895410
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features of combined hepatic carcinoma].
He C; Yin HF; Liu P; Zhang Y; Zhang JB
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):824-8. PubMed ID: 24507101
[TBL] [Abstract][Full Text] [Related]
6. [Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
Du JL; Wang YL; Shi HY; Guo AT; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):309-13. PubMed ID: 22883669
[TBL] [Abstract][Full Text] [Related]
7. Two-in-one: A pooled analysis of primary hepatic neuroendocrine carcinoma combined/collided with hepatocellular carcinoma.
Mao JX; Teng F; Sun KY; Liu C; Ding GS; Guo WY
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):399-403. PubMed ID: 32359724
[No Abstract] [Full Text] [Related]
8. Mixed Primary Hepatocellular Carcinoma and Hepatic Neuroendocrine Carcinoma: Case Report and Literature Review.
Shin WY; Lee KY; Kim KD
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837619
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum alpha-fetoprotein in poorly differentiated adenocarcinoma with neuroendocrine differentiation of the ascending colon: a case report.
Lin HH; Chang CC; Yang SH; Chang SC; Chen WS; Liang WY; Lin JK; Jiang JK
World J Surg Oncol; 2016 Mar; 14():84. PubMed ID: 26976278
[TBL] [Abstract][Full Text] [Related]
10. Combined primary neuroendocrine carcinoma and hepatocellular carcinoma of the liver.
Yang CS; Wen MC; Jan YJ; Wang J; Wu CC
J Chin Med Assoc; 2009 Aug; 72(8):430-3. PubMed ID: 19686999
[TBL] [Abstract][Full Text] [Related]
11. A fat containing combined neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report.
Ikeda A; Aoki K; Terashima T; Itokawa Y; Kokuryu H
Ann Hepatol; 2021; 22():100183. PubMed ID: 32111487
[TBL] [Abstract][Full Text] [Related]
12. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case.
Ishida M; Seki K; Tatsuzawa A; Katayama K; Hirose K; Azuma T; Imamura Y; Abraham A; Yamaguchi A
Surg Today; 2003; 33(3):214-8. PubMed ID: 12658390
[TBL] [Abstract][Full Text] [Related]
13. Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: a case report and literature review.
Nishino H; Hatano E; Seo S; Shibuya S; Anazawa T; Iida T; Masui T; Taura K; Haga H; Uemoto S
Clin J Gastroenterol; 2016 Aug; 9(4):272-9. PubMed ID: 27384317
[TBL] [Abstract][Full Text] [Related]
14. Rare case of a gallbladder neuroendocrine carcinoma.
Fujii M; Saito H; Shiode J
Clin J Gastroenterol; 2019 Feb; 12(1):38-45. PubMed ID: 30003469
[TBL] [Abstract][Full Text] [Related]
15. [A case of primary small cell neuroendocrine carcinoma of the liver].
Kim KJ; Yim HJ; Kim MJ; Choung RS; Yeon JE; Lee HS; Byun KS; Lee SW; Choi JH; Ryu HS; Lee CH; Hyun JH; Lee ES; Kim YS
Korean J Gastroenterol; 2006 Jul; 48(1):37-41. PubMed ID: 16861880
[TBL] [Abstract][Full Text] [Related]
16. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine carcinoma of the liver associated with dermatomyositis: autopsy case and review of the literature.
Yasuda E; Takeshita A; Murata S; Ihaku Y; Nitta T; Akutagawa H; Egashira Y; Shibayama Y
Pathol Int; 2006 Dec; 56(12):749-54. PubMed ID: 17096733
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Tumors of the Breast.
Rosen LE; Gattuso P
Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
[TBL] [Abstract][Full Text] [Related]
19. A resected case of a small hepatocellular carcinoma developing within the bile duct.
Yasui O; Sato T; Andoh H; Kurokawa T; Watanabe D; Sageshima M; Nanjo H
J Hepatobiliary Pancreat Surg; 2004; 11(3):193-6. PubMed ID: 15235893
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma.
Murakami K; Kumata H; Miyagi S; Kamei T; Sasano H
Pathol Int; 2021 Oct; 71(10):682-691. PubMed ID: 34320691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
